340B Insider Summary Report

Compliance and manufacturer restrictions top concerns for providers


Meeting program compliance requirements and pushing back on escalating manufacturer restrictions are the top concerns of pharmacy leaders, as uncovered during the August 2022 Cloudmed 340B Insider interactive webinar. A full 72% of respondents cited one or the other as their primary program concern, with revenue loss largely resulting from discount restrictions ranked third.

Download the full summary report for more information on:

  • Additional industry insights
  • Regulatory updates from the experts
  • Advice on how to offset savings loss
  • What to know about compliance and HRSA audits
  • FAQs answered by an expert panel

Read the new 2023 Revenue Intelligence™ Data and Insights Report to discover data-backed insights that improve RCM processes.